Buprenorphine 69238-1205
Product NDC
69238-1205- Manufacturer
- Amneal Pharmaceuticals Ny Llc
- Dosage Form
- Patch, Extended Release
- Route
- Transdermal
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CIII
- Marketing Start
- April 20, 2020
- Listing Expires
- December 31, 2027
- Application
- ANDA211586
Active Ingredients
| Ingredient | Strength |
|---|---|
| Buprenorphine | 20 ug/h |
Drug Class
Partial Opioid Agonist [EPC]Partial Opioid Agonist [EPC]Partial Opioid Agonists [MoA]
Packaging Options(1)
4 POUCH in 1 CARTON (69238-1205-2) / 1 PATCH in 1 POUCH / 168 h in 1 PATCH